[HTML][HTML] Atherosclerosis: process, indicators, risk factors and new hopes
M Rafieian-Kopaei, M Setorki, M Doudi… - … journal of preventive …, 2014 - ncbi.nlm.nih.gov
Background: Atherosclerosis is the major cause of morbidities and mortalities worldwide. In
this study we aimed to review the mechanism of atherosclerosis and its risk factors, focusing …
this study we aimed to review the mechanism of atherosclerosis and its risk factors, focusing …
Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials
ContextAlthough Chlamydia pneumoniae infection has been associated with the initiation
and progression of atherosclerosis, results of clinical trials investigating antichlamydial …
and progression of atherosclerosis, results of clinical trials investigating antichlamydial …
Distribution of Legionella Species and Serogroups Isolated by Culture in Patients with Sporadic Community-Acquired Legionellosis: An International Collaborative …
VL Yu, JF Plouffe, MC Pastoris, JE Stout… - The Journal of …, 2002 - academic.oup.com
Seroepidemiology, pathology, and animal studies provide evidence for a possible
association between Chlamydia pneumoniae infections and atherosclerosis, coronary heart …
association between Chlamydia pneumoniae infections and atherosclerosis, coronary heart …
The next influenza pandemic: lessons from Hong Kong, 1997.
R Snacken, AP Kendal, LR Haaheim… - Emerging infectious …, 1999 - ncbi.nlm.nih.gov
Abstract The 1997 Hong Kong outbreak of an avian influenzalike virus, with 18 proven
human cases, many severe or fatal, highlighted the challenges of novel influenza viruses …
human cases, many severe or fatal, highlighted the challenges of novel influenza viruses …
Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial
CM Jespersen, B Als-Nielsen, M Damgaard… - Bmj, 2006 - bmj.com
Objective To determine if the macrolide clarithromycin affects mortality and cardiovascular
morbidity in patients with stable coronary heart disease. Design Centrally randomised …
morbidity in patients with stable coronary heart disease. Design Centrally randomised …
Risk factors in coronary atherosclerosis athero-inflammation: the meeting point
R Altman - Thrombosis journal, 2003 - Springer
Following Russel Ross [1], there is now general agreement that vessel wall inflammation
constitutes a major factor in the development of atherosclerosis, atheroma instability and …
constitutes a major factor in the development of atherosclerosis, atheroma instability and …
[HTML][HTML] Chlamydia pneumoniae and atherosclerosis–what we know and what we don't
J Ngeh, V Anand, S Gupta - Clinical microbiology and infection, 2002 - Elsevier
The clinical manifestations of atherosclerosis include coronary artery disease (CAD), stroke,
abdominal aortic aneurysm and peripheral vascular disease. World-wide, CAD and stroke …
abdominal aortic aneurysm and peripheral vascular disease. World-wide, CAD and stroke …
Clarithromycin for 2 weeks for stable coronary heart disease: 6-year follow-up of the CLARICOR randomized trial and updated meta-analysis of antibiotics for coronary …
C Gluud, B Als-Nielsen, M Damgaard… - Cardiology, 2008 - karger.com
Objectives: We have reported increased 2.6-year mortality in clarithromycin-versus placebo-
exposed stable coronary heart disease patients, but meta-analysis of randomized trials in …
exposed stable coronary heart disease patients, but meta-analysis of randomized trials in …
Long-term outcomes of minor dissection at the edge of stents detected with intravascular ultrasound
MK Hong, SW Park, NH Lee, DY Nah… - American Journal of …, 2000 - ajconline.org
Coronary stenting has been accepted as a very effective treatment modality in patients with
coronary artery disease. 1, 2 Poststent high-pressure inflation techniques with the …
coronary artery disease. 1, 2 Poststent high-pressure inflation techniques with the …
Lack of association between first myocardial infarction and past use of erythromycin, tetracycline, or doxycycline.
LA Jackson, NL Smith, SR Heckbert… - Emerging infectious …, 1999 - ncbi.nlm.nih.gov
To evaluate the association of prior treatment with antibiotics active against Chlamydia
pneumoniae with the risk for incident myocardial infarction, we conducted a population …
pneumoniae with the risk for incident myocardial infarction, we conducted a population …